As competition law continues to evolve, it is vital for life sciences IP practitioners in the pharmaceutical and biotech industries to stay informed about enforcement trends, litigation outcomes, and settlements, as well as the broader economic considerations that shape these laws. Points of discussion will include:

• Analyzing key enforcement actions taken by European competition authorities, focusing on cases involving pharmaceutical and biotech companies
• Exploring the influence of EU policies and regulations on competition law, including recent directives and guidelines specific to the life sciences sector
• Reviewing recent high-profile litigation and settlement cases within the EU, assessing their implications for market dynamics and legal strategies
• Understanding how market dynamics, such as pricing strategies and market consolidation, are influencing competition law enforcement and compliance in the EU
• Offering insights into how life sciences companies can adapt their strategies to comply with the changing EU competition law landscape and effectively advocate for their interests